Search research articles
Contact Us
Filters
Showing results (571-580 of 662) with videos related to
Page
of 67
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 15, 2012
New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge
Julie Schanz, Heinz Tüchler, Francesc Solé, et al.
European Heart Journal
|
December 14, 2021
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
Joerg Herrmann, Daniel Lenihan, Saro Armenian, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
March 28, 2022
Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User's Guide for Daily Clinical Practice
Peter Valent, Karin Hartmann, Juliana Schwaab, et al.
Biorxiv : the Preprint Server for Biology
|
October 16, 2024
DNA polymerase theta-mediated DNA repair is a functional dependency and therapeutic vulnerability in DNMT3A deficient leukemia cells
Bac Viet Le, Umeshkumar Vekariya, Monika M Toma, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 10, 2019
Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome
Peter Valent, Cem Akin, Patrizia Bonadonna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 12, 2019
MARS: Mutation-Adjusted Risk Score for Advanced Systemic Mastocytosis
Mohamad Jawhar, Juliana Schwaab, Iván Álvarez-Twose, et al.
Nature Communications
|
October 20, 2019
A kinase-independent role for CDK8 in BCR-ABL1<sup>+</sup> leukemia
Ingeborg Menzl, Tinghu Zhang, Angelika Berger-Becvar, et al.
American Journal of Hematology
|
September 12, 2025
Tissue-Resident Myeloid and Histiocytic Cells in Health and Disease: Novel Emerging Concepts
Peter Valent, Johann Wojta, Petri T Kovanen, et al.
Blood
|
May 23, 2018
Tyrosine kinase inhibitor-induced defects in DNA repair sensitize FLT3(ITD)-positive leukemia cells to PARP1 inhibitors
Silvia Maifrede, Margaret Nieborowska-Skorska, Katherine Sullivan-Reed, et al.
Cancer Research
|
March 4, 2017
Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future
Peter Valent, Cem Akin, Karin Hartmann, et al.
Page
of 67
Search research articles
Search
Showing results (571-580 of 662) with videos related to
Sort By:
Page
of 67
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 15, 2012
New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge
Julie Schanz, Heinz Tüchler, Francesc Solé, et al.
European Heart Journal
|
December 14, 2021
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
Joerg Herrmann, Daniel Lenihan, Saro Armenian, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
March 28, 2022
Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User's Guide for Daily Clinical Practice
Peter Valent, Karin Hartmann, Juliana Schwaab, et al.
Biorxiv : the Preprint Server for Biology
|
October 16, 2024
DNA polymerase theta-mediated DNA repair is a functional dependency and therapeutic vulnerability in DNMT3A deficient leukemia cells
Bac Viet Le, Umeshkumar Vekariya, Monika M Toma, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 10, 2019
Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome
Peter Valent, Cem Akin, Patrizia Bonadonna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 12, 2019
MARS: Mutation-Adjusted Risk Score for Advanced Systemic Mastocytosis
Mohamad Jawhar, Juliana Schwaab, Iván Álvarez-Twose, et al.
Nature Communications
|
October 20, 2019
A kinase-independent role for CDK8 in BCR-ABL1<sup>+</sup> leukemia
Ingeborg Menzl, Tinghu Zhang, Angelika Berger-Becvar, et al.
American Journal of Hematology
|
September 12, 2025
Tissue-Resident Myeloid and Histiocytic Cells in Health and Disease: Novel Emerging Concepts
Peter Valent, Johann Wojta, Petri T Kovanen, et al.
Blood
|
May 23, 2018
Tyrosine kinase inhibitor-induced defects in DNA repair sensitize FLT3(ITD)-positive leukemia cells to PARP1 inhibitors
Silvia Maifrede, Margaret Nieborowska-Skorska, Katherine Sullivan-Reed, et al.
Cancer Research
|
March 4, 2017
Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future
Peter Valent, Cem Akin, Karin Hartmann, et al.
Page
of 67